Global burden of cancers attributable to infections in 2008: a review and synthetic analysis - PubMed (original) (raw)
Review
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel et al. Lancet Oncol. 2012 Jun.
Free article
Abstract
Background: Infections with certain viruses, bacteria, and parasites have been identified as strong risk factors for specific cancers. An update of their respective contribution to the global burden of cancer is warranted.
Methods: We considered infectious agents classified as carcinogenic to humans by the International Agency for Research on Cancer. We calculated their population attributable fraction worldwide and in eight geographical regions, using statistics on estimated cancer incidence in 2008. When associations were very strong, calculations were based on the prevalence of infection in cancer cases rather than in the general population. Estimates of infection prevalence and relative risk were extracted from published data.
Findings: Of the 12·7 million new cancer cases that occurred in 2008, the population attributable fraction (PAF) for infectious agents was 16·1%, meaning that around 2 million new cancer cases were attributable to infections. This fraction was higher in less developed countries (22·9%) than in more developed countries (7·4%), and varied from 3·3% in Australia and New Zealand to 32·7% in sub-Saharan Africa. Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses were responsible for 1·9 million cases, mainly gastric, liver, and cervix uteri cancers. In women, cervix uteri cancer accounted for about half of the infection-related burden of cancer; in men, liver and gastric cancers accounted for more than 80%. Around 30% of infection-attributable cases occur in people younger than 50 years.
Interpretation: Around 2 million cancer cases each year are caused by infectious agents. Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide.
Funding: Fondation Innovations en Infectiologie (FINOVI) and the Bill & Melinda Gates Foundation (BMGF).
Copyright © 2012 Elsevier Ltd. All rights reserved.
Comment in
- Global burden of infection-related cancer revisited.
Danaei G. Danaei G. Lancet Oncol. 2012 Jun;13(6):564-5. doi: 10.1016/S1470-2045(12)70176-6. Epub 2012 May 9. Lancet Oncol. 2012. PMID: 22575586 No abstract available.
Similar articles
- Global burden of cancers attributable to infections in 2012: a synthetic analysis.
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Plummer M, et al. Lancet Glob Health. 2016 Sep;4(9):e609-16. doi: 10.1016/S2214-109X(16)30143-7. Epub 2016 Jul 25. Lancet Glob Health. 2016. PMID: 27470177 - Cancers in Australia in 2010 attributable to infectious agents.
Antonsson A, Wilson LF, Kendall BJ, Bain CJ, Whiteman DC, Neale RE. Antonsson A, et al. Aust N Z J Public Health. 2015 Oct;39(5):446-51. doi: 10.1111/1753-6405.12445. Aust N Z J Public Health. 2015. PMID: 26437730 Free PMC article. - Cancer and infection: estimates of the attributable fraction in 1990.
Pisani P, Parkin DM, Muñoz N, Ferlay J. Pisani P, et al. Cancer Epidemiol Biomarkers Prev. 1997 Jun;6(6):387-400. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9184771 Review. - Global burden of human papillomavirus and related diseases.
Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Forman D, et al. Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Vaccine. 2012. PMID: 23199955 Review. - The global health burden of infection-associated cancers in the year 2002.
Parkin DM. Parkin DM. Int J Cancer. 2006 Jun 15;118(12):3030-44. doi: 10.1002/ijc.21731. Int J Cancer. 2006. PMID: 16404738
Cited by
- Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.
Miller AL, Bessho S, Grando K, Tükel Ç. Miller AL, et al. Front Immunol. 2021 Feb 26;12:638867. doi: 10.3389/fimmu.2021.638867. eCollection 2021. Front Immunol. 2021. PMID: 33717189 Free PMC article. Review. - The Follow-Up Necessity in Human Papilloma Virus-Positive vs. Human Papilloma Virus-Negative Oral Mucosal Lesions: A Retrospective Study.
Rushiti A, Castellani C, Cerrato A, Fedrigo M, Sbricoli L, Bressan E, Angelini A, Bacci C. Rushiti A, et al. J Clin Med. 2023 Dec 21;13(1):58. doi: 10.3390/jcm13010058. J Clin Med. 2023. PMID: 38202065 Free PMC article. - Uptake and predictors of anal cancer screening in men who have sex with men.
D'Souza G, Rajan SD, Bhatia R, Cranston RD, Plankey MW, Silvestre A, Ostrow DG, Wiley D, Shah N, Brewer NT. D'Souza G, et al. Am J Public Health. 2013 Sep;103(9):e88-95. doi: 10.2105/AJPH.2013.301237. Epub 2013 Jul 18. Am J Public Health. 2013. PMID: 23865658 Free PMC article. - Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Kreimer AR, Brennan P, Lang Kuhs KA, Waterboer T, Clifford G, Franceschi S, Michel A, Willhauck-Fleckenstein M, Riboli E, Castellsagué X, Hildesheim A, Fortner RT, Kaaks R, Palli D, Ljuslinder I, Panico S, Clavel-Chapelon F, Boutron-Ruault MC, Mesrine S, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Cross AJ, Bueno-de-Mesquita HB, Vineis P, Larrañaga N, Pala V, Sánchez MJ, Navarro C, Barricarte A, Tumino R, Khaw KT, Wareham N, Boeing H, Steffen A, Travis RC, Quirós JR, Weiderpass E, Pawlita M, Johansson M. Kreimer AR, et al. J Clin Oncol. 2015 Mar 10;33(8):877-84. doi: 10.1200/JCO.2014.57.8435. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667279 Free PMC article. - Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.
Lemoine M, Nayagam S, Thursz M. Lemoine M, et al. Future Virol. 2013 Apr;8(4):371-380. doi: 10.2217/fvl.13.11. Future Virol. 2013. PMID: 23662157 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials